Interestingly, even though melanoma patients, who experienced a resistance to BRAF inhibitors, showed an up-regulation of PD-L1 (114), a large number of studies reported that the inducible PD-L1 expression is not correlated with BRAF mutational status (112, 115). This evidence concerns the gene CD274 and melanoma.